From October 8th to 20th, the three-day global premier pharmaceutical event—CPhI Worldwide 2024—successfully concluded in Milan, Italy. The event attracted over 62,000 participants from more than 266 countries and region……
We are excited to announce that on July 2st, Dorra Pharmaceuticals officially established its first overseas office in Europe. This strategic move marks a significant milestone in our journey towards international growth……
From June 29 to 22, the 22nd CPHI China 2024 was successfully held at the Shanghai New International Expo Centre. This prestigious event gathered over 3,500 leading companies from the global pharmaceutical industry and a……
From April 27th to 29th, 2024, the 22st CPHI Japan concluded successfully in Tokyo. As Japan’s leading pharmaceutical exhibition, the event attracted nearly 600 exhibitors from around the world and set a record for atten……
Recently, Dorra Pharma has received two major honors: the Certificate of Export Commodity Brand issued by the China Council for the Promotion of International Trade (CCPIT), and selection into the China Customs Sample En……
From October 24th to 26th, 2023, a major event in the global pharmaceutical industry, CPHI Worldwide, was successfully held in Barcelona, Spain. As the world's largest pharmaceutical trade exhibition, this event succ……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
